In this interview, News-Medical talks to Dr. Amy Sheng, the head of CRO at Sino Biological, about
current developments in the field of vaccine development through recombinant techniques.
In this interview, Dr. Shebna Massey discusses neurodegenerative diseases such as Alzheimer's, Parkinson's, Huntington's, and more. She also discusses and explores new therapeutic targets and biomarkers for these diseases.
Sino Biological's Beacon® single-cell screening platform combines unique and novel technologies into a single platform, allowing for unprecedented diversity in B cells while generating high-quality cells.